Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bethanechol chloride for pseudomembranous oral candidosis in cancer patients with salivary gland dysfunction
2006-004282-34Phase 2Completed
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bethanechol in oral candidiasis, sponsored by Royal Marsden NHS Foundation Trust. Primary endpoint: Clinical resolution of oral candidosis at day 14. Started Sep 2006; status: completed.
02
Drugs
bethanechol
03
Conditions
oral candidiasis
Beyond the preview
Go deeper on 2006-004282-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004282-34.